Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

▴ Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets
Alembic receives USFDA approval for their erectile dysfunction drug

Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Tablets, 2.5 mg (base),5 mg (base), 10 mg (base), and 20 mg (base). The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Levitra Tablets,2.5 mg, 5 mg, 10 mg, and 20 mg, of Bayer Healthcare Pharmaceuticals Inc. (Bayer).

Vardenafil Hydrochloride Tablets are indicated for the treatment · of erectile dysfunction.Vardenafil Hydrochloride Tablets have an estimated market size of US$ 35 million for twelve months ending June 2020 according to IQVIA.Alembic now has a total of 127 ANDA approvals (112 final approvals and 15 tentative approvals) from USFDA.

Recently, Alembic Pharmaceuticals Limited also announced that the Company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Empagliflozin and Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg, of Boehringer lngelheim Pharmaceuticals, Inc. (Boehringer lngelheim). Empagliflozin and Metformin Hydrochloride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate Empagliflozin and Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg have an estimated market size of US$ 172 million for twelve months ending March 2020 according to IQVIA. Alembic is currently in litigation with Boehringer lngelheim in the District Court of Delaware and the launch of the product will depend on litigation outcome.

Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company that has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India. Alembic's brands, marketed through a marketing team of over 5000 are well recognized by doctors and patients

Tags : #Alembic #VardenafilHydrochloride #ErectileDysfunction #USFDAApproval #AlembicNews #Empagliflozin #MetforminHydrochloride #LatestPharmaNewsAug5 #PharmaNewsUpdateAug5 #LevitraTablets #BayerHealthcare

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Lupin Launches Lapatinib TabletsSeptember 30, 2020
Ajinomoto Bio-Pharma Services and DNDi Partner to develop Critical Immunomodulator September 30, 2020
Lupin launches Lapatinib Tablets secures FDA approvalSeptember 30, 2020
Synthetic Biology introduces NanoSyrinxSeptember 30, 2020
Regular check-up & annual mammography are necessary to detect breast cancer earlySeptember 30, 2020
Regular use of acid influx drugs increase the risk of type-2 diabetesSeptember 30, 2020
Current pandemic introduces research culture in Ayush disciplineSeptember 30, 2020
Maharashtra govt calls for cancellation of Dandiya, Garba, other cultural programmes during ensuing Navratri, Durga PujaSeptember 30, 2020
Allotment of seats for admission in 1st year MBBS course will be done per existing policies: JIPMERSeptember 30, 2020
WHO to investigate allegations of sexual exploitation and abuse in Ebola response in the Democratic Republic of the CongoSeptember 30, 2020
South Korea puts virus curbs in place ahead of Chuseok holidaysSeptember 30, 2020
COVID-19 infection cases rising among U.S. childrenSeptember 30, 2020
India sustains steady trend of dipping %Active CasesSeptember 30, 2020
Private hospitals & diagnostic centres overcharging patients even for basic health services: Maharashtra Health MinisterSeptember 30, 2020
Centre releases COVID-19 Safe Workplace Guidelines for IndustrySeptember 30, 2020
COVID-19 recovery rate in country reaches 83.33%September 30, 2020
A special strategy has prepared by UP CM to tackle COVID-19September 29, 2020
China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
RDIF and Trinity Pharmaceuticals will provide COVID vaccine to NepalSeptember 29, 2020